DCP3 Series Acknowledgments Disease Control Priorities, third edition (DCP3) compiles We thank the many contractors and consultants the global health knowledge of institutions and experts who provided support to specific volumes in the form of from around the world, a task that required the efforts economic analytical work, volume coordination, chap- of over 500 individuals, including volume editors, ter drafting, and meeting organization: the Center for chapter authors, peer reviewers, advisory committee Disease Dynamics, Economics, and Policy; Center for members, and research and staff assistants. For each Chronic Disease Control; Center for Global Health of these contributions we convey our acknowledge- Research; Emory University; Evidence to Policy Initiative; ment and appreciation. First and foremost, we would Public Health Foundation of India; QURE Healthcare; like to thank our 31 volume editors who provided the University of California, San Francisco; University of intellectual vision for their volumes based on years of Waterloo; University of Queensland; and the World Health professional work in their respective fields, and then Organization. dedicated long hours to reviewing each chapter, pro- We are tremendously grateful for the wisdom and viding leadership and guidance to authors, and fram- guidance provided by our advisory committee to the ing and writing the summary chapters. We also thank editors. Steered by Chair Anne Mills, the advisory com- our chapter authors who collectively volunteered their mittee assures quality and intellectual rigor of the high- time and expertise to writing over 160 comprehensive, est order for DCP3. evidence-based chapters. The U.S. Institute of Medicine, in collaboration We owe immense gratitude to the institutional spon- with the Inter-Academy Medical Panel, coordinated the sor of this effort: The Bill & Melinda Gates Foundation. peer-review process for all DCP3 chapters. Patrick Kelley, The Foundation provided sole financial support of Gillian Buckley, Megan Ginivan, and Rachel Pittluck the Disease Control Priorities Network. Many thanks managed this effort and provided critical and substan- to Program Officers Kathy Cahill, Philip Setel, Carol tive input. Medlin, and (currently) Damian Walker for their The Office of the Publisher at the World Bank pro- thoughtful interactions, guidance, and encouragement vided exceptional guidance and support throughout the over the life of the project. We also wish to thank Jaime demanding production and design process. We would Sepulveda for his longstanding support, including chair- particularly like to thank Carlos Rossel, the publisher; ing the Advisory Committee for the second edition Mary Fisk, Nancy Lammers, Devlan O’Connor, Rumit and, more recently, demonstrating his vision for DCP3 Pancholi, and Deborah Naylor for their diligence and while he was a special advisor to the Gates Foundation. expertise. Additionally, we thank Jose de Buerba, Mario We are also grateful to the University of Washington’s Trubiano, Yulia Ivanova, and Chiamaka Osuagwu of Department of Global Health and successive chairs King the World Bank for providing professional counsel on Holmes and Judy Wasserheit for providing a home-base communications and marketing strategies. for the DCP3 Secretariat, which included intellectual Several U.S. and international institutions contrib- collaboration, logistical coordination, and administra- uted to the organization and execution of meetings that tive support. supported the preparation and dissemination of DCP3. 381 We would like to express our appreciation to the follow- Reproductive and maternal health volume consulta- ing institutions: tion Nov 2013) · National Cancer Institute and Union for · University of Bergen, consultation on equity (June International Cancer Control (Cancer consultation 2011) Nov. 2013) · University of California, San Francisco, surgery volume consultations (April 2012, October 2013, Carol Levin provided outstanding governance for February 2014) cost and cost-effectiveness analysis. Stéphane Verguet · Institute of Medicine, first meeting of the Advisory added invaluable guidance in applying and improv- Committee to the Editors ACE (March 2013) ing the extended cost-effectiveness analysis method. · Harvard Global Health Institute, consultation Shane Murphy, Zachary Olson, Elizabeth Brouwer, on policy measures to reduce incidence of non- and Kristen Danforth provided exceptional research communicable diseases (July 2013) assistance and analytic assistance. Brianne Adderley · Institute of Medicine, systems strengthening meeting ably managed the budget and project processes. The (September 2013) efforts of these individuals were absolutely critical · Center for Disease Dynamics, Economics, and to producing this series and we are thankful for their Policy (Quality and Uptake meeting Sept 2013, commitment. 382 DCP3 Series Acknowledgments Series and Volume Editors SERIES EDITORS Hellen Gelband Hellen Gelband is Associate Director for Policy at the Dean T. Jamison Center for Disease Dynamics, Economics & Policy Dean Jamison is a Senior Fellow in Global Health (CDDEP). Her work spans infectious disease, particu- Sciences at the University of California, San Francisco, larly malaria and antibiotic resistance, and noncommu- and an Emeritus Professor of Global Health at the nicable disease policy, mainly in low- and middle- income University of Washington. He previously held aca- countries. Before joining CDDEP, then Resources for the demic appointments at Harvard University and the Future, she conducted policy studies at the (former) University of California, Los Angeles; he was an Congressional Office of Technology Assessment, the economist on the staff of the World Bank, where Institute of Medicine of the U.S. National Academies, he was lead author of the World Bank’s World and a number of international organizations. Development Report 1993: Investing in Health. He was lead editor of DCP2. He holds a PhD in economics Susan Horton from Harvard University and is an elected member Susan Horton is the CIGI chair in global health eco- of the Institute of Medicine of the U.S. National nomics in the Balsillie School of International Affairs at Academy of Sciences. He recently served as Co-Chair the University of Waterloo. She has worked in over 20 and Study Director of The Lancet’s Commission on low- and middle-income countries and has consulted Investing in Health. for the World Bank, the Asian Development Bank, several United Nations agencies, and the International Rachel Nugent Development Research Centre, among others. She led Rachel Nugent is a Research Associate Professor in the paper on nutrition for the Copenhagen Consensus the Department of Global Health at the University in 2008, when micronutrients were ranked as the top of Washington. She was formerly Deputy Director of development priority. She has served as associate pro- Global Health at the Center for Global Development, vost of graduate studies at the University of Waterloo, Director of Health and Economics at the Population vice-president academic at Wilfrid Laurier University in Reference Bureau, Program Director of Health and Waterloo, and interim dean at the University of Toronto Economics Programs at the Fogarty International Center at Scarborough. of the National institutes of Health, and senior econ- omist at the Food and Agriculture Organization of Prabhat Jha the United Nations. From 1991–97, she was associate Prabhat Jha is the founding director of University professor and department chair in economics at Pacific of Toronto’s Centre for Global Health Research and Lutheran University. She has advised the World Health University of Toronto Endowed Professor in Disease Organization, the U.S. government, and nonprofit orga- Control, Canada Research Chair at the Dalla Lana nizations on the economics and policy environment of School of Public Health. He is lead investigator of the noncommunicable diseases. Million Death Study in India, which quantifies the 383 causes of death and key risk factors in over two million Society; Faculty Chief Examiner, Ghana College of homes over a 14-year period. He is also Scientific Physicians and Surgeons; Council Member, West African Director of the Statistical Alliance for Vital Events, which College of Surgeons; and Chairman, Ghana Health aims to expand reliable measurement of causes of death Workforce Observatory. worldwide. He also conducts studies on epidemiology Through the Ghana Cleft Foundation, a nonprofit and economics of tobacco control worldwide. organization that he cofounded, he provides outreach cleft surgery for remote communities throughout Ramanan Laxminarayan Ghana. Ramanan Laxminarayan is Vice President for Research He was the Founding President of the Pan African and Policy at the Public Health Foundation of India, and Association for Cleft Lip and Palate and served for he directs the Center for Disease Dynamics, Economics a number of years on the International Outreach & Policy in Washington, D.C., and New Delhi. His Committee of the American Cleft Palate−Craniofacial research deals with the integration of epidemiological Association and the Advisory Board of the Center for models of infectious diseases and drug resistance into Global Health, University of Michigan. the economic analysis of public health problems. He was His research collaborations include head and one of the key architects of the Affordable Medicines neck cancer, cleft lip and palate, injury, emergency Facility